MSL Best Practices Field Guide

MSL BEST PRACTICES FIELD-GUIDE [GO]

This MSL Best Practices field guide is based on the questions and answers contributed by field-medical science liaison program leadership participating in the 2008 MSL Best Practices Executive Intelligence Network.

Table of Contents | Go to Product Page for Previews

  • The Case of the Missing Company Names 4
  • Given the pending revisions to the PhRMA code of conduct in 2009, how restrictive is your company with respect to MSL and Med Affairs personnel with healthcare providers? 6
  • What are the appropriate metrics to use to measure the value of a MSL organization? 8
  • Brand New MSL Team Struggling with Establishing Metrics 12
  • How are you and your company handling retention of MSLs? 15
  • What career paths do you offer your MSLs? 16
  • Does anyone have a company-wide KOL database (CR&D, MSL, Commercial, Medical) that they utilize to track KOL touches? 17
  • Do you require Medical Affairs physicians to document KOL interactions? 19
  • What is the best KOL management system available? 18
  • How many days in the field are your MSLs expected to work? 19
  • Are your MSLs able to disseminate slides to thought leaders upon request? 21
  • What is the role, if any, of your MSLs in identifying and facilitating CME activities? 22
  • If your MSLs provide slide to thought leaders, are these on-label or off-label slides? 23
  • Does you MSL team undergo any regular knowledge- or therapeutic assessment? 24
  • This training approach is being billed as ‘Best Practices’ but it feels like a test to the MSLs. 25
  • What types of training programs do you utilize for your MSLs to help them build their knowledge base? 31
  • Does your MSL program hire only terminal degree individuals? 33
  • Do your MSLs conduct proactive interactions with Thought Leaders? 35
  • MSLs and Licensure 36
  • What is the Scope of Responsibilities for Your MSL Managers? 38
  • How do you develop your MSLs’ slides? 40
  • With Small Pharma, how many products is appropriate for an MSL to manage? 41
  • Justifying Consolidating 3 Teams into 1 MSL Team 43
  • Is there any data out there that talks about physician preference as to whom they would like to have call on them from Pharma (i.e. MSL v. commercial rep)? 49